|

EU-sourced Keytruda® Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • mAbxience Research S.L.1

Indications

  • Non-Squamous Non-Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.